Receptor Life Sciences
PrivateLast Round
Series A
Extension
Apr 7, 2022
Total Funding Raised
$38.7M
Company Overview
Receptor Life Sciences operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Series A Extension round in April 2022.
Receptor Life Sciences is a pharmaceutical company that develops innovative therapies for central nervous system disorders using FDA-approved drug delivery technologies for cannabinoid products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Receptor Life Sciences Comparables
Compare Receptor Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ANANDA Scientific | 79% | |
| UCB | 76% | |
| Synendos Therapeutics | 71% |
For institutional investors. Book with your work email.
Receptor Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 7, 2022 | ||||
| Series A | Oct 29, 2018 |
For institutional investors. Book with your work email.
Receptor Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Granite Point Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2022
$9.7M round led by Granite Point Capital
- Oct 29, 2018
$29M round completed.
For institutional investors. Book with your work email.
Receptor Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Receptor Life Sciences's valuation, stock price, and market status.
Is Receptor Life Sciences a public or private company?
Receptor Life Sciences is a private company.
What is the current stock price of Receptor Life Sciences?
Receptor Life Sciences is a private company, so its shares have no public market price. Caplight tracks Receptor Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Receptor Life Sciences worth (valuation)?
Valuation information for Receptor Life Sciences is not publicly available.
Can I buy Receptor Life Sciences stock?
Receptor Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Receptor Life Sciences's last funding round?
Receptor Life Sciences's most recent funding round was Series A Extension on April 7, 2022.
Who are the main investors in Receptor Life Sciences?
Key investors in Receptor Life Sciences include Granite Point Capital.
Will Receptor Life Sciences IPO soon?
No public IPO plans have been announced for Receptor Life Sciences.
How can I track Receptor Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Receptor Life Sciences's shares on secondary markets.